Table 5.
Summary of AE.
| Author, year | Number of trails (participants) | AE not reported | No AE occurred | AE occurred | AE description (number of cases) |
|---|---|---|---|---|---|
| Hu et al., 2009 [13] | 12 (950) | 3 | 5 | 4 | T: dizziness (2), rash (2); C: allergies (3); rash (1) |
|
| |||||
| Xu et al., 2010 [14] | 9 (996) | 3 | 3 | 3 | T: headache (1), skin flushing (1), gastrointestinal symptoms (3); unstable blood pressure (2) |
|
| |||||
| Xiong et al., 2014 [15] | 21 (2725) | 21 | 0 | 0 | / |
|
| |||||
| Ye et al., 2010 [16] | 45 (4027) | 23 | NA | NA | T: headache (5); C: rash (2), pruritus (2), injection site bruising (1), bleeding gums (1) |
|
| |||||
| Yang and Zeng, 2012 [17] | 27 (2583) | 8 | 17 | 2 | T: rash (2), fever (2) |
|
| |||||
| Liu et al., 2014 [18] | 9 (885) | NA | NA | NA | NA |
|
| |||||
| Peng et al., 2010 [19] | 29 (3191) | NA | NA | NA | T: gastrointestinal symptoms (1), fever (2), dizziness (3), rash (2); C: rash (1), fever (2) |
|
| |||||
| Ma et al., 2012 [20] | 14 (1112) | 6 | 5 | 3 | Ecchymosis, T/C unknown |
T, treatment group; C, control group; NA, not available.